New phase 2 trial findings published in The Lancet Diabetes & Endocrinology suggest burosumab treatment for X-linked hypophosphataemia (XLH) may begin in the first year of life. Unpick the findings in our latest article.
New phase 2 trial findings published in The Lancet Diabetes & Endocrinology suggest burosumab treatment for X-linked hypophosphataemia (XLH) may begin in the first year of life. Unpick the findings in our latest article.
數十萬無碼AV線上免費觀看，每日更新最新AV，也支援投影到電視機。可依番號、女優或作品系列名稱搜尋AV。免費加入會員後可任意收藏影片供日後觀賞。
